← Insider buys
KITE

Kite Pharma, Inc.

VP, Product Sciences Marc Better sold $554K of Kite Pharma, Inc.

Sold$553,788
$61.53Price
9,000Shares
−54%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Jan 4. Filed Tue, Jan 5, 2:45 PM ET, during the session. Not investment advice.